PEDIATRIC MULTI SYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH COVID 19
- Recently a possible link has been reported between COVID-19 and Pediatric Multi-System Inflammatory Syndrome (PMIS) temporally associated with COVID-19.
- As of May 12th, 102 suspect cases of PMIS have been reported by hospitals in New York State and are under investigation by the New York State Department of Health.
Clinical Criteria: An individual aged < 21 years with:
- A minimum one-day history of subjective OR objective fever (≥ 100.4° F/38° C); AND
- Hospitalization; AND
One or more of the following:
- Hypotension or shock (cardiogenic or vasogenic)
- Features of severe cardiac illness including but not limited to myocarditis, pericarditis, or valvulitis, significantly elevated troponin/pro-BNP, or coronary artery abnormalities
- Other severe end-organ involvement including but not limited to neurological or renal disease (excluding severe respiratory disease alone)
Two or more of the following:
- Maculopapular rash
- Bilateral non-purulent conjunctivitis
- Mucocutaneous inflammatory signs (mouth, hands, or feet)
- Acute gastrointestinal symptoms (diarrhea, vomiting, or abdominal pain); AND
- The absence of a more likely diagnosis of the illness, e.g., bacterial sepsis or other viral infection.
One or more of the following exposures in the 6 weeks prior to the onset of symptoms:
- Close contact with an individual with laboratory-confirmed SARS-CoV-2 infection.1
- Close contact with an individual with illness clinically compatible with COVID-19 disease who had close contact with an individual with laboratory-confirmed SARS-CoV-2 infection.1
- Travel to or residence in an area with sustained, ongoing community transmission of SARS-CoV-2.
Click here to book an appointment.